Bay Medical Uses World's Smallest Heart Pump for Critically Ill Heart Patients
Bay Medical’s Heart Institute is now using Abiomed’s Impella 2.5 heart pump, the World’s Smallest Heart Pump, as a new treatment option to assist critically ill heart patients. Interventional cardiologists Samir Patel, M.D. and Amir Haghighat, M.D. have used the new device with the first procedure being performed locally in March.
The Impella 2.5 is a catheter-based heart pump which received clearance by the Food and Drug Administration a little more than two years ago. As the World’s Smallest Heart Pump, the Impella works by temporarily relieving the heart’s pumping function and providing the time needed to perform life-saving interventions. This is especially helpful in patients who might normally be a candidate for open heart surgery due to the severity of their disease, but the surgery is not an option due to other health factors.
The Impella is used in minimally invasive procedures in the catheterization laboratory (cath lab) and is inserted through a small incision in the groin area in order to access the femoral artery. The device is then guided into the left ventricle where up to 2.5 liters of blood are delivered by the pump into the ascending aorta, providing the heart with continuous blood flow. It takes just a few minutes to place the Impella before the procedure begins.
Bay Medical has joined approximately 500 other hospitals in the U.S. that are now using Impella 2.5 and are committed to optimal heart recovery, and is the only hospital in the Florida panhandle using this technology. “Our team can now perform cutting-edge, life-saving cardiovascular procedures,” says interventional cardiologist Samir Patel, M.D. “The Impella is a breakthrough technology that offers a minimally invasive approach in cardiac treatment and will help change the industry standard of care in the cath lab with its seamless and immediate circulatory support for critical patients.”